Enhabit, Inc. (NYSE:EHAB) Shares Acquired by D. E. Shaw & Co. Inc.

D. E. Shaw & Co. Inc. boosted its stake in Enhabit, Inc. (NYSE:EHAB - Free Report) by 33.2% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,004,215 shares of the company's stock after buying an additional 250,215 shares during the quarter. D. E. Shaw & Co. Inc. owned approximately 2.00% of Enhabit worth $7,843,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently made changes to their positions in the stock. JPMorgan Chase & Co. boosted its position in Enhabit by 37.8% during the third quarter. JPMorgan Chase & Co. now owns 305,245 shares of the company's stock worth $2,411,000 after acquiring an additional 83,707 shares during the last quarter. Paradice Investment Management LLC grew its position in shares of Enhabit by 12.8% in the fourth quarter. Paradice Investment Management LLC now owns 1,780,113 shares of the company's stock valued at $13,903,000 after purchasing an additional 201,997 shares during the period. Corient Private Wealth LLC acquired a new position in Enhabit in the fourth quarter valued at $79,000. Price T Rowe Associates Inc. MD lifted its position in Enhabit by 10.3% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 43,851 shares of the company's stock worth $343,000 after buying an additional 4,100 shares during the period. Finally, Rhumbline Advisers grew its holdings in Enhabit by 2.8% in the 4th quarter. Rhumbline Advisers now owns 80,760 shares of the company's stock valued at $631,000 after buying an additional 2,211 shares during the period.

Enhabit Trading Up 0.2%

NYSE:EHAB traded up $0.03 on Wednesday, hitting $10.64. 44,767 shares of the stock were exchanged, compared to its average volume of 337,544. The stock has a fifty day moving average of $8.62 and a 200-day moving average of $8.25. The stock has a market cap of $538.52 million, a PE ratio of -4.57 and a beta of 1.61. The company has a current ratio of 1.46, a quick ratio of 1.46 and a debt-to-equity ratio of 0.85. Enhabit, Inc. has a fifty-two week low of $6.85 and a fifty-two week high of $10.79.

Enhabit (NYSE:EHAB - Get Free Report) last announced its quarterly earnings results on Wednesday, May 7th. The company reported $0.10 earnings per share for the quarter, beating analysts' consensus estimates of $0.07 by $0.03. Enhabit had a negative net margin of 11.24% and a positive return on equity of 1.67%. The firm had revenue of $259.90 million for the quarter, compared to analysts' expectations of $266.11 million. As a group, equities analysts expect that Enhabit, Inc. will post 0.22 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Separately, Jefferies Financial Group reissued a "buy" rating on shares of Enhabit in a research report on Thursday, March 6th.

Enhabit Company Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.